No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

David Klein, MD New CEO of MarinHealth: to Take the Reins of MarinHealth September 1, 2020

Former President & CEO of Dignity Health’s Saint Francis Memorial Hospital and St. Mary’s Medical Center to Take the Reins of MarinHealth September 1, 2020

Editor: What To Know

  • He also sits on the Board of Directors of the Saint Francis Foundation and the Board of the Hacienda Surgery Center and serves as an ex-officio member of the St.
  • “My predecessor, Lee Domanico, has truly set the benchmark for excellence in healthcare, and I intend to build upon the incredible legacy he has given to the community of Marin and the Bay Area at large.
  • Klein currently serves as the Chair of the San Francisco Section of the Hospital Council of Northern and Central California and is a member of the San Francisco Marin Medical Society.

David Klein, MD, has been named the new Chief Executive Officer (CEO) of MarinHealth effective September 1, 2020. Dr. Klein will succeed MarinHealth’s current CEO, Lee Domanico, who is retiring September 30. Mr. Domanico will move into an advisory role for the month of September to ensure a smooth transition.

David Klein, a resident of Marin, has stated that his highest priorities for MarinHealth are maintaining safety, excellent outcomes, and creating an outstanding patient-centric experience.

Dr. Klein comes to MarinHealth after serving as President and CEO of Dignity Health’s Saint Francis Memorial Hospital and St. Mary’s Medical Center in San Francisco. Saint Francis Memorial Hospital is a community based, non-profit, 294 bed acute care hospital while St Mary’s Medical Center is a 275 bed acute care hospital. Both are part of the Dignity Health system.

“David Klein is an outstanding selection to take the mantle and lead MarinHealth to new levels of success,” said Lee Domanico, Chief Executive Officer, MarinHealth. “Based on his prior experience as both a healthcare executive and practicing surgeon, David is well equipped to face the challenges within today’s healthcare industry. As a resident of Marin, he will have the best interests of the community in mind. I am pleased with the choice made by the MarinHealth Medical CenterBoard of Directors for David to build upon the momentum we’ve established these past 10 years.”

In addition to his new role as CEO at MarinHealth, Dr. Klein currently serves as the Chair of the San Francisco Section of the Hospital Council of Northern and Central California and is a member of the San Francisco Marin Medical Society. He also sits on the Board of Directors of the Saint Francis Foundation and the Board of the Hacienda Surgery Center and serves as an ex-officio member of the St. Mary’s Medical Center Foundation Board of Directors.

While serving as President and CEO of Saint Francis Memorial Hospital and St. Mary’s Medical Center, Klein worked to foster a culture of clinical excellence and accountability. Dr. Klein developed and grew talent, ensuring a highly functional team with responsible leadership. He also led succession planning, drove culture, maintained labor relationships, led strategic growth through implementing new business strategies and built outstanding physician and external partnerships.

Before Dignity Health, Dr. Klein was Chief Operating Officer and then President of the 574-bed Baylor Scott & White Health All Saints Medical Center in Fort Worth, Texas. There, he introduced key strategic growth initiatives and highly innovative programs. As a result, the hospital received numerous accolades for service line excellence and overall hospital quality, including top hospital rankings from U.S. News and World Report.

Dr. Klein has also served as Administrator of Presbyterian Hospital of Denton in Denton, Texas, and as CEO of Cedar Park Regional Medical Center in Austin, Texas.

Dr. Klein practiced general surgery for 14 years before becoming a full-time hospital administrator. He received his bachelor’s degree from the University of Southern California, his medical degree from the University of New Mexico and his master’s degree in Business Administration from the University of California, Irvine.

For many years, Dr. Klein has served on numerous community boards including the American Heart Association, March of Dimes, American Cancer Society and Fort Worth Chamber of Commerce.

“I could not be more excited about this role and the opportunity to contribute to the organization’s stellar reputation for high-quality, safe, innovative, and patient-centered care,” said Dr. Klein. “My predecessor, Lee Domanico, has truly set the benchmark for excellence in healthcare, and I intend to build upon the incredible legacy he has given to the community of Marin and the Bay Area at large. I also look forward to working closely with the exceptional and extremely dedicated team of professionals at MarinHealth—especially during these unprecedented times—to ensure that we continue to uphold the great values and traditions that have made us the Healing Place for our community.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy